Literature DB >> 5022049

Verapamil in cardiac arrhythmias.

J R Milne, C B Boothby, C S Garrard, D Pickering.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5022049      PMCID: PMC1788220          DOI: 10.1136/bmj.2.5809.348-c

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.

Authors:  D L Murdoch; G D Thomson; G G Thompson; G D Murray; M J Brodie; G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

2.  Verapamil in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D M Krikler; R A Spurrell
Journal:  Postgrad Med J       Date:  1974-07       Impact factor: 2.401

Review 3.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 4.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

Review 5.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

Review 6.  Calcium antagonists. Clinical use in the treatment of arrhythmias.

Authors:  B N Singh; K Nademanee; S H Baky
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

7.  Additive antianginal effect of verapamil in patients receiving propranolol.

Authors:  M Bassan; D Weiler-Ravell; O Shalev
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-10

8.  Modulation of cardiac impulse generation and conduction by nifedipine and verapamil analyzed by a refined surface ECG technique in Langendorff perfused guinea pig hearts.

Authors:  G Stark; U Stark; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1988 Mar-Apr       Impact factor: 17.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.